Is it the right time to buy CGEN stock - Unlock powerful market trend analysis - jammulinksnews.com
9 hours ago • Google News
Compugen (CGEN)
US$ 1.78-1.66%
Price Chart
Key Statistics
Market Cap
$ 139.95M
P/E Ratio
0.00
Revenue (TTM)
$ 27.59M
Volume
212.22K
52W High
$ 2.66
52W Low
$ 1.13
Dividend Yield
0.00%
Beta
2.58
Technicals
50-Day MA
1.6086
200-Day MA
1.6681
52 Week High
2.66
52 Week Low
1.13
About CGEN
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United .
Employees
74
Headquarters
Holon, Israel
CEO
Dr. Anat Cohen-Dayag Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg